TurtleTree Founders Fengru Lyn and Max Rye. It was one of seven finalists in the Temasek Liveability Challenge, vying for the first prize of $1 million undiluted funding. Image Credit: KBW Ventures

Dubai: Saudi owned KBW Ventures was one of the investors in Singapore-based biotech company TurtleTree Labs’ latest round of funding. The startup intends to create “real” milk from mammalian cells… without the need for animals.

“KBW Ventures has invested in the seed round building on our initial commitment during TurtleTree’s pre-seed raise,” said Prince Khaled bin Alwaleed bin Talal Al Saud, CEO of KBW Ventures. “We see the founding team commitment and the potential of this company and its technology as a winning combination.

“Now more than ever, people are waking up to the benefits of food technology and the massive positive implications of innovations in cellular agriculture.”

In a statement, TurtleTree said: “The goal of creating milk from animal cells provides a solution towards sustainable dairy production, and also help to strengthen Singapore's long-term food diversification efforts.”

Other investors taking part included Green Monday Ventures, CPT Capital, Artesian, and New Luna Ventures.